Evidence map›Paper›PMID 27279097›Full record

ArticleJournal of general internal medicine2016

Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.

Ethan A Halm, Elisabeth F Beaber, Dale McLerran, Jessica Chubak, Douglas A Corley, Carolyn M Rutter, Chyke A Doubeni, Jennifer S Haas, Bijal A Balasubramanian

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Journal of general internal medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Novel Application of Predictive Modeling: A Tailored Approach to Promoting HCC Surveillance in Patients With Cirrhosis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Longitudinal Adherence With Stool-Based Testing for Colorectal Cancer Screening in Four United States Health Systems.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2026
    Article
  8. Article
  9. It Is a Good Idea, but Are They Willing? Assessing Pharmacist Willingness to Deliver Colorectal Cancer Screening.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Randomized controlled trials of biomarker targets.Clinical trials (London, England) · 2023
    Article
  17. Persistent Disparities in Colorectal Cancer Screening: A Tell-Tale Sign for Implementing New Guidelines in Younger Adults.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Ethan A HalmDepartments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA. ethan.halm@utsouthwestern.edu.
Elisabeth F BeaberDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Dale McLerranDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Jessica ChubakGroup Health Research Institute, Seattle, WA, USA.
Douglas A CorleyDivision of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Carolyn M RutterRAND Corporation, Santa Monica, CA, USA.
Chyke A DoubeniDepartment of Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jennifer S HaasDivision of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA, USA.
Bijal A BalasubramanianDepartment of Epidemiology, Human Genetics & Environmental Sciences, University of Texas School of Public Health, Dallas, TX, USA.
Fred Hutch Cancer Center · USBrigham and Women's Hospital · USKaiser Permanente · USKaiser Permanente Washington Health Research Institute · USRAND Corporation · USThe University of Texas Southwestern Medical Center · USUniversity of Pennsylvania · US

Funding

UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
Optimizing the use of colonoscopy for CRC screening in a large community-basedU54CA163262 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CORLEY, DOUGLAS ALLEN, DOUBENI, CHYKE ABADAMA · 2011 to 2017
$9.6M
Parkland-UT Southwestern PROSPR Center Colon Cancer Screening in a Safety netU54CA163308 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI SKINNER, CELETTE SUGG · 2011 to 2017
$8.0M
PROSPR Statistical Coordinating Center (PSCC)U01CA163304 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BARLOW, WILLIAM E, THORNQUIST, MARK · 2011 to 2017
$7.5M
Penn Center for Innovation in Personalized Breast ScreeningU54CA163313 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ARMSTRONG, KATRINA, SCHNALL, MITCHELL D. · 2011 to 2017
$7.4M
Studying Colorectal Cancer Effectiveness of Screening Strategies (SuCCESS)U54CA163261 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CHUBAK, JESSICA · 2011 to 2017
$7.3M
Vermont Screening Process Documentation UnitU54CA163303 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SPRAGUE, BRIAN L · 2011 to 2017
$6.4M
Promoting personalized decisions for breast cancer screening for women AND theirU54CA163307 · NCI · DARTMOUTH COLLEGE · PI HAAS, JENNIFER S, ONEGA, TRACY · 2011 to 2017
$6.1M
UT Southwestern Center of Patient-Centered Outcomes Research (PCOR)R24HS022418 · AHRQ · UT SOUTHWESTERN MEDICAL CENTER · PI HALM, ETHAN A · 2013 to 2017
$5.0M
AHRQ HHS R24 HS022418NCATS NIH HHS UL1 TR001105NCI NIH HHS U01 CA163304NCI NIH HHS U54 CA163261NCI NIH HHS U54 CA163262NCI NIH HHS U54 CA163303NCI NIH HHS U54 CA163307NCI NIH HHS U54 CA163308NCI NIH HHS U54 CA163313
6 · The paper itself

Abstract

backgroundPopulation outreach strategies are increasingly used to improve colorectal cancer (CRC) screening. The influence of primary care on cancer screening in this context is unknown.

objectiveTo assess associations between primary care provider (PCP) visits and receipt of CRC screening and colonoscopy after a positive fecal immunochemical (FIT) or fecal occult blood test (FOBT).

designPopulation-based cohort study.

participantsA total of 968,072 patients ages 50-74 years who were not up to date with CRC screening in 2011 in four integrated healthcare systems (three with screening outreach programs using FIT kits) in the Population-Based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium. MEASURES: Demographic, clinical, PCP visit, and CRC screening data were obtained from electronic health records and administrative databases. We examined associations between PCP visits in 2011 and receipt of FIT/FOBT, screening colonoscopy, or flexible sigmoidoscopy (CRC screening) in 2012 and follow-up colonoscopy within 3 months of a positive FIT/FOBT in 2012. We used multivariable logistic regression and propensity score models to adjust for confounding.

resultsFifty-eight percent of eligible patients completed a CRC screening test in 2012, most by FIT. Those with a greater number of PCP visits had higher rates of CRC screening at all sites. Patients with ≥1 PCP visit had nearly twice the adjusted-odds of CRC screening (OR = 1.88, 95 % CI: 1.86-1.89). Overall, 79.6 % of patients with a positive FIT/FOBT completed colonoscopy within 3 months. Patients with ≥1 PCP visit had 30 % higher adjusted odds of completing colonoscopy after positive FIT/FOBT (OR = 1.30; 95 % CI: 1.22-1.40).

conclusionsPatients with a greater number of PCP visits had higher rates of both incident CRC screening and colonoscopy after positive FIT/FOBT, even in health systems with active population health outreach programs. In this era of virtual care and population outreach, primary care visits remain an important mechanism for engaging patients in cancer screening.

Indexed as

AftercareAgedColonoscopyColorectal NeoplasmsEarly Detection of CancerFemaleHealth PromotionHumansMaleMiddle AgedOccult BloodOffice VisitsOutcome Assessment, Health CarePatient Acceptance of Health CarePrimary Health CareUnited Statescolorectal cancer screeningpopulation health outreachprimary care

Identifiers

PMID27279097
PMCPMC5023609
OpenAlexW2416556204

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.